DAX24.853 ±-0,0%Est506.011 -0,4%MSCI World4.343 -0,1%Top 10 Crypto8,3300 -2,6%Nas22.597 -2,0%Bitcoin55.136 -2,2%Euro1,1870 -0,1%Öl67,60 -2,9%Gold4.922 -3,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Siemens Energy ENER6Y Siemens 723610 Mercedes-Benz Group (ex Daimler) 710000 SAP 716460 Deutsche Telekom 555750 Rheinmetall 703000 NVIDIA 918422 BASF BASF11 Gerresheimer A0LD6E Amazon 906866 Lufthansa 823212 Microsoft 870747 Allianz 840400 Bayer BAY001 DroneShield A2DMAA
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX letztlich kaum bewegt -- US-Börsen rot -- Mercedes-Benz: Gewinneinbruch -- Siemens erhöht Ergebnisprognose -- TKMS, Deutsche Börse, DroneShield, Birkenstock, Micron, Palantir, Fastly im Fokus
Top News
Coinbase-Aktie dennoch fester: Gewinneinbruch - Umsatz bleibt unter Erwartungen Coinbase-Aktie dennoch fester: Gewinneinbruch - Umsatz bleibt unter Erwartungen
Analysten: Gold und Silber werden immer mehr zu einem Spekulationsobjekt Analysten: Gold und Silber werden immer mehr zu einem Spekulationsobjekt
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Noch bis 14. April bei der Commerzbank gebührenfrei in Vanguard-ETFs investieren

TransMedics Group Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
108,25 EUR -4,30 EUR -3,82 %
BMN
128,65 USD -4,64 USD -3,48 %
BTT
TransMedics Group jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.4,01 Mrd. EUR

KGV61,92Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2PH5P

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS89377M1099

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolTMDX

TransMedics Group Aktien News

DatumMeistgelesen
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of TransMedics Group, Inc. - TMDX
PR NewswireTMDX Investors Have Opportunity to Join TransMedics Group, Inc. Securities Fraud Investigation with the Schall Law Firm
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of TransMedics Group, Inc. - TMDX
PR NewswireTransMedics Responds to Inaccurate and Misleading Claims in Recent Short-Seller Report
PR NewswireTransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Appoints Gerardo Hernandez as Chief Financial Officer and Provides Updated 2024 Financial Outlook
PR NewswireTransMedics to Host Investor & Analyst Day on December 10, 2024
PR NewswireTransMedics to Participate in the Piper Sandler 36th Annual Healthcare Conference
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Third Quarter 2024 Financial Results
PR NewswireTransMedics to Report Third Quarter 2024 Financial Results on October 28, 2024
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireThe Ensign Group Set to Join S&P MidCap 400; Curbline Properties & TransMedics Group to Join S&P SmallCap 600
PR NewswireTransMedics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Second Quarter 2024 Financial Results
PR NewswireTransMedics to Present at the Canaccord Genuity 44th Annual Growth Conference
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Report Second Quarter 2024 Financial Results on July 31, 2024
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports First Quarter 2024 Financial Results
PR NewswireTransMedics to Report First Quarter 2024 Financial Results on April 30, 2024
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Present at Upcoming March Investor Conferences
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Fourth Quarter and Full Year 2023 Financial Results
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Present at the Piper Sandler 35th Annual Healthcare Conference
PR NewswireTransMedics Reports Third Quarter 2023 Financial Results
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Report Third Quarter 2023 Financial Results on November 6, 2023
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

TransMedics Group News

TransMedics Group News: auf dieser Seite finden Sie alle TransMedics Group News und Nachrichten zur TransMedics Group Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch TransMedics Group News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um TransMedics Group News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.